Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J holds off on volatile M&A market but has plenty of cash for a deal
Endpoints
Tue, 10/18/22 - 10:02 pm
Tags:
JNJ, M&A
COVID vaccine boosts J&J pharma sales in Q3
Medical Marketing and Media
Tue, 10/18/22 - 10:53 am
Tags:
JNJ, COVID-19, vaccines, earnings
J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules
Fierce Pharma
Thu, 10/13/22 - 11:50 pm
Tags:
i20 Therapeutics, Sanofi, JNJ, large molecule drugs
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
Tags:
GSK, RSV, vaccines, clinical trials, Pfizer, JNJ, Moderna Therapeutics, RSVPreF3
BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica
Fierce Pharma
Wed, 10/12/22 - 11:00 am
Tags:
BeiGene, AbbVie, JNJ, Imbruvica, blood cancers, Brukinsa
Biogen Looks at Former J&J Exec as Potential CEO Candidate
BioSpace
Mon, 10/10/22 - 07:00 pm
Tags:
Biogen, Pharma CEOs, JNJ, Mathai Mammen
Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
Tags:
JNJ, Janssen, ulcerative colitis, guselkumab, golimumab
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
Tags:
JNJ, gene therapy, clinical trials, retinal disease, MeiraGTx, X-linked retinitis pigmentosa
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
Tags:
FDA, GSK, Amicus Therapeutics, AstraZeneca, Novartis, Supernus, JNJ, Ipsen, Y-mAbs Therapeutics
Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff
Fierce Pharma
Wed, 09/28/22 - 11:05 am
Tags:
JNJ, branding, Kenvue, consumer health, spinoffs
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Tags:
Takeda, JNJ, Novartis, ADHD, MHRA, Concerta XL, Ritalin XL, Equasym XL
Johnson & Johnson defends bankruptcy play in appeals court, but plaintiffs call it a 'bad faith' move
Fierce Pharma
Tue, 09/20/22 - 08:33 pm
Tags:
JNJ, legal, bankruptcy
J&J opens new research hub near San Francisco
BioPharma Dive
Tue, 09/20/22 - 08:32 pm
Tags:
JNJ, San Francisco, biotech hubs, R&D
Why Novavax and Johnson & Johnson Stocks Slipped Monday
Motley Fool
Mon, 09/19/22 - 10:00 pm
Tags:
JNJ, Novavax, vaccines, Joe Biden, COVID-19
J&J settles gender discrimination and retaliation allegations involving former CEO and R&D head
Endpoints
Sun, 09/18/22 - 10:37 pm
Tags:
JNJ, legal, gender discrimination, Alex Gorsky, retaliation
J&J expands in Ireland with a $100M+ investment for contact lens manufacturing site
Endpoints
Sun, 09/18/22 - 10:20 pm
Tags:
JNJ, JNJ Vision, Ireland, contact lens
Former J&J executive settles with company in workplace discrimination lawsuit
Fierce Pharma
Thu, 09/8/22 - 04:27 pm
Tags:
JNJ, legal, gender discrimination
J&J's Biosense Launches New Mapping Catheter
Medical Devices and Diagnostics Industry
Wed, 09/7/22 - 10:20 am
Tags:
devices, Medtech, JNJ, Biosense Webster, cardiac mapping, cardiac arrhythmias
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
Tags:
FDA, Bristol Myers Squibb, deucravacitinib, Amylyx Pharmaceuticals, ALS, AMX0035, Ferring Pharmaceuticals, microbiome, RBX2660, Revance Therapeutics, Bluebird Bio, Spectrum Pharmaceuticals, JNJ, Oncopeptides
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
Tags:
JNJ, Janssen, clinical trials, Darzalex, Revlimid, Velcade, Multiple Myeloma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.